Fondazione Don Carlo Gnocchi ONLUS
Florence, 50143, Italy
NCT Number: NCT06622473
The study protocol focuses on evaluating the Virtual Eggs Test (VET) as a tool for assessing hand dexterity and grip strength control in post-stroke patients. The study aims to validate the reliability and concurrent validity of the VET, comparing its outcomes with established tests like the Nine Hole Peg Test (NHPT), the Motricity Index, the Semmes-Weinstein Monofilament Test (SWMT), and the Abilhand-ULA questionnaire
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Not applicable
Florence, 50143, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each participant will perform the VET, with their most affected hand, followed by the VET with the less affected hand.
Time frame: First Session (Test)
This refers to the grip strength threshold required to avoid breaking fragile objects during the test. The VET measures the participant's ability to regulate grip strength and dexterity, with the threshold ranging from 1 to 20. Lower numbers indicate that less force is needed to break the object, reflecting greater control over fine motor skills.
Time frame: First Session (Test)
A test that measures tactile sensitivity by applying calibrated filaments to the skin. The pressure exerted by the filaments ranges from 0.07 to 300 grams, with lower values indicating greater sensitivity and higher values indicating reduced sensation. The range helps to detect sensory deficits in the hands post-stroke.
Time frame: First Sessione (Test)
A clinical assessment used to evaluate strength in the upper limb. It involves scoring the patient's ability to perform specific movements on a scale from 0 to 100, where 0 indicates no movement and 100 represents normal strength. Scores between 57 to 100 suggest varying degrees of strength in the upper limb.
Time frame: First Session (Test)
A timed test that assesses manual dexterity. The participant is asked to place and remove nine pegs from holes as quickly as possible. The total time is recorded, typically ranging from 20 to 60 seconds depending on the severity of impairment. Lower times indicate better dexterity.
Time frame: First Session (Test)
A self-assessment questionnaire used to measure manual ability in daily activities for individuals with upper limb impairments. Scores range from 0 to 2 for each item, where 0 means the task is impossible, 1 means it is difficult, and 2 means the task can be performed easily.
Time frame: Second Session (Re-Test)
This refers to the grip strength threshold required to avoid breaking fragile objects during the test. The VET measures the participant's ability to regulate grip strength and dexterity, with the threshold ranging from 1 to 20. Lower numbers indicate that less force is needed to break the object, reflecting greater control over fine motor skills.
Time frame: First Session (Test)
Measurement of the average test duration in minutes
Time frame: Second Session (Re-Test)
Measurement of the average test duration in minutes
Fondazione Don Carlo Gnocchi ETS
Other
Acronym: VET_STROKE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07411664
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kaposvár, Somogy County, Hungary
View Trial DetailsNCT07719387
Brain Diseases, Cardiovascular Diseases
Stony Brook, New York, United States
View Trial DetailsNCT07681102
Brain Diseases, Cardiovascular Diseases
Berkeley, California, United States
View Trial DetailsNCT04534556
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial Details